NCT00015054View on ClinicalTrials.gov

Methylphendidate Treatment of Cocaine Dependent Patients With Attention Deficit Hyperactivity Disorder - 3

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 1998

Primary Completion Date

October 31, 1999

Study Completion Date

November 30, 1999

Conditions
Cocaine-Related Disorders
Interventions
DRUG

Methylphenidate

Trial Locations (1)

45220

Cincinnati MDRU, Cincinnati

All Listed Sponsors
collaborator

Cincinnati MDRU

OTHER

lead

National Institute on Drug Abuse (NIDA)

NIH

NCT00015054 - Methylphendidate Treatment of Cocaine Dependent Patients With Attention Deficit Hyperactivity Disorder - 3 | Biotech Hunter | Biotech Hunter